Quantcast

Latest AbioMed Stories

2008-10-31 12:00:32

Abiomed, Inc. (NASDAQ: ABMD) announced today that on Monday, November 10, 2008, the Company will release second fiscal quarter 2009 results. The Company will host a conference call to discuss the results on Monday, November 10, 2008, at 8:00 a.m. ET. Michael R.

2008-10-09 00:00:39

-- Investor and Analyst Meeting on October 13 from 5:30 - 6:30 p.m. -- Customer Symposium Featuring Leading Clinician Presentations on October 13 from 7:00 - 9:30 p.m.

2008-10-01 15:00:50

Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.

2008-09-16 15:00:38

Abiomed, Inc. (NASDAQ: ABMD) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the UBS Global Life Sciences Conference on Monday, September 22, 2008 at 10:30 a.m. ET. The conference will be held at the Grand Hyatt in New York City, New York.

2008-09-02 09:00:43

Abiomed, Inc. (NASDAQ: ABMD) announced today that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008 at 9:45 a.m. ET.

2008-08-22 12:00:52

Abiomed, Inc. (NASDAQ: ABMD) today announced the completion of the public offering of 2,419,932 shares of its common stock at $17.3788 per share. The net proceeds to Abiomed from the offering were approximately $41.7 million, after deducting the underwriting discount and estimated offering expenses.

2008-08-07 09:01:05

Abiomed, Inc. (NASDAQ: ABMD) today announced first quarter of fiscal 2009 revenue of $16.4 million, up 16% compared to revenue of $14.1 million for the same period of fiscal 2008. Recent financial and operating highlights include: -- On June 2, 2008, Abiomed announced that it had received U.S.

2008-07-31 12:01:06

Abiomed, Inc. (NASDAQ: ABMD) announced today that on Thursday, August 7, 2008, the Company will release first fiscal quarter 2009 results. The Company will host a conference call to discuss the results on Thursday, August 7, 2008, at 8:00 a.m. ET. Michael R.

2007-10-25 15:00:48

Abiomed, Inc. (NASDAQ: ABMD) formally announced the results of its Impella® 2.5 PROTECT I safety trial for the first time at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium and main sessions.

2006-09-05 16:49:28

By Lisa Richwine WASHINGTON (Reuters) - Seriously ill heart failure patients expected to live only a month and ineligible for transplant can get an implant of a permanent artificial heart, U.S. health officials ruled on Tuesday.


Latest AbioMed Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »
Word of the Day
adustion
  • The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
  • In medicine, cauterization.
The word 'adustion' comes from the Latin 'adustio', 'burning'.
Related